{"database": "lobbying", "table": "lobbying_activities", "rows": [[1908900, "0bbe162c-7c4b-4d2b-8c7c-265be052f2ec", "Q4", "RED+BLUE STRATEGIES", 400693064, "VIRTUS PHARMACEUTICALS", 2016, "fourth_quarter", "HCR", "Issues related to the treatment of certain generic medications", "Food & Drug Administration (FDA),SENATE", 40000, null, 0, 0, "2017-01-04T13:06:31-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1908900"], "units": {}, "query_ms": 62.58988007903099, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}